# Sarilumab Effect on the Pharmacokinetics of Simvastatin

> **NCT02017639** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 19 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** sarilumab SAR153191 (REGN88)
- **DRUG:** simvastatin

## Key facts

- **NCT ID:** NCT02017639
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2016-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02017639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02017639, "Sarilumab Effect on the Pharmacokinetics of Simvastatin". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT02017639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*